Schizophrenia

Diabetes Screening Inadequate in Mentally Ill

New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective cohort study that analyzed diabetes screening prevalence and predictors of screening among adults in the California […]

Read More
DETAIL

Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia

Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients with recent onset of schizophrenia (n=86) were randomized to receive long-acting injectable risperidone or oral […]

Read More
DETAIL

The Myth of Schizophrenia as a Progressive Brain Disease

Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain tissue loss over the early years of illness. Zipursky and colleagues challenge this concept. Schizophrenia Bulletin [More…]

Read More
DETAIL

Violence and Schizophrenia: The Subject of ’60 Minutes’

The CBS television program “60 Minutes” aired a special report about the issue of recent tragic mass shootings as preventable tragedies and the failures of the US mental health system. The show interviewed experts Jeffrey Lieberman, M.D., president of APA and chair of psychiatry at Columbia University, and E. Fuller Torrey, M.D., executive director of the […]

Read More
DETAIL

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases and the latest science with Hippocrates.  This model of education was maintained throughout the centuries […]

Read More
DETAIL

Early Detection of Schizophrenia: The Time Is Now

In an editorial in Psychiatric News by APA President Jeffrey Lieberman, MD, he describes that “we are at another game-changing moment in psychiatry with the rise of the early detection and intervention strategy (EDIS). This new therapeutic strategy and model of care could have a significant effect on our ability to treat and limit the […]

Read More
By R Kennedy | News . Schizophrenia
DETAIL

Pain conditions among veterans with schizophrenia or bipolar disorder

A study published in General Hospital Psychiatry evaluated the rates of chronic, noncancer pain conditions in patients diagnosed with schizophrenia or bipolar disorder within the Veterans Health Administration (VHA) System. Researchers used a cross-sectional design that used administrative data extracted from VHA treatment records of all individuals receiving VHA services in one year (N=751). They […]

Read More
DETAIL

Essential Components of First-Episode Psychosis Services

A study published in May 1st, 2013 Psychiatric Services identified essential evidence-based components of first-episode psychosis services. The research took place in two stages. First a systematic literature review, then, a consensus-building technique, the Delphi, was used with an international panel of experts. The panelists were presented the evidence-based components identified in the review, together […]

Read More
DETAIL